brought to you by
|8:30AM-9:15AM||HCV: Therapeutics and Progress toward elimination||Marisel Bosques, MD|
|9:15AM-10:00AM||Effect of COVID on HIV, effect OF HIV on COVID||Vilmary Sierra, MD|
|10:15AM-11:00AM||Inflammation and comorbidities during ART||Nelson Vallejo, MD|
|11:00AM-11:45||New development in Transmitted and acquired drug resistance.||Julio Baco, MD|
|11:45AM-12:30PM||Lunch / Speaker Program by Janssen |
Shifting HIV Care from Acute to Chronic: Evaluating Considerations in Rapid Initiation
|Wilfredo Cuevas, MD|
|12:30PM-1:15PM||New PrEP agents and formulations||Lizette Santiago, MD|
|1:25PM-2:15PM||Innate Immune Defenses against HIV-1 and Sars CoV 2||Roberto Calderon, MD|
registration has closed
With an HIVTMD website account, you will enter your personal information only once.
Then, for every event you wish to attend, your registration with require only one click.
Access to the event will be sent to the email provided on this account.
Please create an account or login if you already have one.